Myriad Genetics | MYGN - Betriebsaufwand

Aktienkurs
4.78
Täglich Wechseln
-0.01 -0.21%
Monatlich
2.14%
Jährlich
-35.58%
Q2 Prognose
4.68




Betriebsaufwand Veränderung Datum
Agilent USD 1.44B 27M 2025-12
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Bio-Rad Laboratories USD 6.74B 6.16B 2025-09
Bruker USD 900.9M 124.3M 2025-12
Danaher USD 52.95B 47.61B 2026-03
Illumina USD 903M 69M 2025-12
J&J USD 17.44B 1.53B 2026-03
Mettler Toledo International USD 777.8M 42.3M 2025-12
Myriad Genetics USD 212.8M 16.2M 2025-12
OraSure Technologies USD 40.35M 2.45M 2025-12
Pacific Biosciences Of California USD 97.83M 41.29M 2025-12
Quest Diagnostics USD 2.5B 76M 2026-03
Quidel USD 760.9M 1.28B 2025-12
Repligen USD 177.94M 1.82M 2025-12
Revvity USD 626.22M 25.62M 2025-12
Standard Biotools USD 45.72M 2.7M 2025-12
Thermo Fisher Scientific USD 9.09B 821M 2026-03
Veracyte USD 116M 7.24M 2025-12
Waters USD 661.85M 1.67B 2025-12